Study of KPL-387 for returning pericarditis
Part of Heart & circulation clinical trials.
This study tests a new medicine, KPL-387, for people whose pericarditis keeps coming back despite standard treatments. It aims to see if this medicine can reduce flare-ups and help you feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pericarditis that keeps coming back.
- You still have pain or other symptoms even though you are already taking standard medicines.
- You weigh at least 40 kg (about 88 pounds).
- You must be taking NSAIDs, colchicine, or steroids for your condition.
- You do not have any active or untreated infections, history of tuberculosis, HIV, or a weak immune system.
- You have not had cancer in the last 5 years (except some minor skin cancers or early cervical cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new drug, KPL-387, can keep your pericarditis under control as your only treatment, after you have been stable on other medicines. It is for people whose pericarditis is well controlled now but who have had flares in the past.
This trial tests if CardiolRx can help people with recurrent pericarditis (inflammation of the heart lining) who are stable on an IL-1 blocker and are planning to stop it. Researchers will see if CardiolRx can prevent a recurrence when the current treatment is tapered off.
This trial tests an experimental drug called VTX2735 for people with recurring pericarditis (inflammation around the heart). It aims to see if the drug can help reduce pain and inflammation during a flare-up.
This study compares different imaging methods (like MRI and PET scans) to see which is better at detecting inflammation in the heart's lining. It aims to help doctors choose the best way to manage and treat recurrent pericarditis.
This trial tests a new treatment called FKC289 for people whose membranous nephropathy (a kidney condition where the immune system attacks the kidney's filters) has come back or not improved with other treatments. The goal is to see if FKC289 is safe and can reduce protein in the urine, which indicates how well the kidney is working.
This study analyzes pericardial fluid (the fluid around your heart) to understand why pericarditis comes back. If you have pericarditis or other heart fluid buildup requiring drainage, or if you're having heart surgery, you may be able to participate.
Hear when a new Pericarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.